Financial Performance Highlights
- Commercial CDMO dispatches reached Rs. 58 crore during Q1 FY27
- Year-over-year revenue growth of 207% (2.3X)
- Year-over-year EBITDA growth of 394%
- API business returned to healthy profitability
- Operating leverage beginning to show through operational execution
Business Strategy Update
Morepen is transitioning from commodity APIs to innovation-led manufacturing with commercial validation of the Morepen 2.0 strategy. The CDMO journey has entered commercial scale with long-duration customer programs generating recurring revenues at higher margins, representing global platform validation.
Capacity Expansion Plans
- Scaling manufacturing capacity to meet global CDMO demand
- Capacity augmentation scheduled for Q2 FY28 to support larger global CDMO opportunities
- Building resilient infrastructure for risk mitigation and long-term customer confidence
Technology Roadmap
Current Capabilities: Small molecules, process chemistry, commercial APIs & CDMO
Emerging Focus: Oligos & new modalities, specialty APIs, difficult-to-make molecules
Next Phase: Complex chemistry, advanced intermediates, hi-potency APIs
Future Direction: New technologies & innovations, selective capability-led expansion
Sustainability Initiatives
- Zero liquid discharge operations
- Solar initiatives implementation
- Cleaner manufacturing processes
- Sustainable operations supporting long-term global growth
Medical Devices Business
Expanding from devices to a chronic-care health platform described as a scalable healthcare platform with recurring consumables revenue.
Outlook and Growth Strategy
Near Term Focus: Commercial execution, capacity expansion, and platform depth
Medium Term Objectives:
- Commercial CDMO supplies expansion
- API profitability recovery continuation
- Capacity utilization optimization
- New customer opportunities development
- Operating leverage realization
Safe Harbor Statement
The presentation contains forward-looking statements about business strategy, growth plans, manufacturing expansion, regulatory developments, market opportunities, future financial performance, operating leverage, and industry outlook, subject to various risks and uncertainties including market conditions, regulatory environment, customer demand, competitive intensity, pricing pressures, supply chain dynamics, currency fluctuations, and technological changes.